United States · FDA National Drug Code directory
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49884-786_9ce53e8f-235a-4ebc-b1b1-4e764daacab2
- Product NDC
- 49884-786
- Form
- TABLET, FILM COATED
- Composition / generic term
- olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161026
- Source listing expiry
- 20271231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 20 mg/1
- AMLODIPINE BESYLATE — 5 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, FILM COATED in 1 BOTTLE (49884-786-09) · 49884-786-09
- 30 TABLET, FILM COATED in 1 BOTTLE (49884-786-11) · 49884-786-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →